Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Neuroscience
|
April 1, 1995
Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain
J Diaz, D Lévesque, C H Lammers, et al.
Biological Psychiatry
|
December 15, 1995
Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II
C H Lammers, D Garcia-Borreguero, J Schmider, et al.
The American Journal of Psychiatry
|
November 1, 1994
Low lumbar bone mineral density in patients with major depression
U Schweiger, M Deuschle, A Körner, et al.
The American Journal of Psychiatry
|
January 1, 1996
Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects
I J Heuser, U Schweiger, U Gotthardt, et al.
Journal of Neurochemistry
|
January 1, 1996
Arachidonate 5-lipoxygenase and its activating protein: prominent hippocampal expression and role in somatostatin signaling
C H Lammers, P Schweitzer, P Facchinetti, et al.
Journal of Clinical Psychopharmacology
|
June 1, 1997
Pulse-dosing and conventional application of doxepin: effects on psychopathology and hypothalamus-pituitary-adrenal (HPA) system
M Deuschle, J Schmider, B Weber, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 1, 1997
Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls
M Deuschle, U Schweiger, B Weber, et al.
Life Sciences
|
January 1, 1997
With aging in humans the activity of the hypothalamus-pituitary-adrenal system increases and its diurnal amplitude flattens
M Deuschle, U Gotthardt, U Schweiger, et al.
Human Molecular Genetics
|
May 20, 1999
PQBP-1, a novel polyglutamine tract-binding protein, inhibits transcription activation by Brn-2 and affects cell survival
M Waragai, C H Lammers, S Takeuchi, et al.
Depression and Anxiety
|
October 24, 1998
Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment
I Heuser, G Bissette, M Dettling, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Neuroscience
|
April 1, 1995
Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain
J Diaz, D Lévesque, C H Lammers, et al.
Biological Psychiatry
|
December 15, 1995
Combined dexamethasone/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II
C H Lammers, D Garcia-Borreguero, J Schmider, et al.
The American Journal of Psychiatry
|
November 1, 1994
Low lumbar bone mineral density in patients with major depression
U Schweiger, M Deuschle, A Körner, et al.
The American Journal of Psychiatry
|
January 1, 1996
Pituitary-adrenal-system regulation and psychopathology during amitriptyline treatment in elderly depressed patients and normal comparison subjects
I J Heuser, U Schweiger, U Gotthardt, et al.
Journal of Neurochemistry
|
January 1, 1996
Arachidonate 5-lipoxygenase and its activating protein: prominent hippocampal expression and role in somatostatin signaling
C H Lammers, P Schweitzer, P Facchinetti, et al.
Journal of Clinical Psychopharmacology
|
June 1, 1997
Pulse-dosing and conventional application of doxepin: effects on psychopathology and hypothalamus-pituitary-adrenal (HPA) system
M Deuschle, J Schmider, B Weber, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 1, 1997
Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls
M Deuschle, U Schweiger, B Weber, et al.
Life Sciences
|
January 1, 1997
With aging in humans the activity of the hypothalamus-pituitary-adrenal system increases and its diurnal amplitude flattens
M Deuschle, U Gotthardt, U Schweiger, et al.
Human Molecular Genetics
|
May 20, 1999
PQBP-1, a novel polyglutamine tract-binding protein, inhibits transcription activation by Brn-2 and affects cell survival
M Waragai, C H Lammers, S Takeuchi, et al.
Depression and Anxiety
|
October 24, 1998
Cerebrospinal fluid concentrations of corticotropin-releasing hormone, vasopressin, and somatostatin in depressed patients and healthy controls: response to amitriptyline treatment
I Heuser, G Bissette, M Dettling, et al.
Page
of 4